Regulation of angiogenic factors by the PI3K/Akt pathway in A549 lung cancer cells under hypoxic conditions

The aim of the present study was to investigate the influence of hypoxia and PI3K inhibition on angiogenic factors in A549 lung cancer cells. A549 cells were treated with the PI3K inhibitor LY294002 under normoxic and hypoxic conditions. Untreated cells were used as the control group and those treated by the inhibitor, as the suppression group. The cells were further divided based on normoxic or hypoxic conditions and named: Normoxic control group, normoxic suppression group, hypoxic control group and hypoxic suppression group. Expression levels of hypoxia-inducible factor (HIF)-1α and AKT1 mRNA in all groups were determined by reverse transcriptase-quantitative polymerase chain reaction and concentrations of vascular endothelial growth factor (VEGF), angiotensin II (ANG-II), transforming growth factor (TGF)-α/β1, and tumor necrosis factor (TNF)-α in the culture supernatant were measured by enzyme-linked immunosorbent assay. The expression levels of HIF-1α and AKT1 mRNA in the hypoxic control group were higher than those in the normoxic control group and the expression levels of HIF-1α and AKT1 mRNA in the hypoxic control group were higher than those in the hypoxic suppression group. Compared to the normoxic control and normoxic suppression groups, the concentrations of VEGF and TNF-α in supernatant were higher in the hypoxic control and hypoxic suppression groups, respectively. However, TGF-α and TGF-β1 demonstrated the opposite trend of the aforementioned factors. The concentration of ANG-II in the hypoxic suppression group was higher than that in the normoxic suppression group. In addition, compared to the normoxic control group and hypoxic control group, the concentrations of VEGF and TGF-β1 in supernatant were lower in the normoxic suppression group and in the hypoxic suppression group, respectively. In conclusion, the results of the present study suggest that hypoxia can stimulate A549 lung cancer cells to secrete VEGF and TNF-α and inhibit TGF-α and TGF-β1. The ability of A549 cells to secrete VEGF and TGF-β1 is regulated by PI3K/Akt, and ANG-II expression may be regulated by the PI3K/Akt pathway under hypoxic condition.

[1]  Hyo-Jong Lee,et al.  Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway , 2015, Cellular Oncology.

[2]  B. Jeon,et al.  Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. , 2014, Toxicology.

[3]  P. Thompson,et al.  Lung cancer neovascularisation: Cellular and molecular interaction between endothelial and lung cancer cells. , 2014, Immunobiology.

[4]  Yi Ji,et al.  Signaling pathways in the development of infantile hemangioma , 2014, Journal of Hematology & Oncology.

[5]  Steffen Jung,et al.  On-site education of VEGF-recruited monocytes improves their performance as angiogenic and arteriogenic accessory cells , 2013, The Journal of experimental medicine.

[6]  Julie Guillemette,et al.  Macrophage Migration Inhibitory Factor Antagonist Blocks the Development of Endometriosis In Vivo , 2012, PloS one.

[7]  Shiwu Wu,et al.  [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry]. , 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[8]  F. Aqil,et al.  Promising molecular targeted therapies in breast cancer , 2011, Indian journal of pharmacology.

[9]  B. Ratner,et al.  VEGF Induces Differentiation of Functional Endothelium From Human Embryonic Stem Cells: Implications for Tissue Engineering , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[10]  J. S. Rao,et al.  MMP‐2 alters VEGF expression via αVβ3 integrin‐mediated PI3K/AKT signaling in A549 lung cancer cells , 2009, International journal of cancer.

[11]  E. Raymond,et al.  mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work? , 2008, British Journal of Cancer.

[12]  Zuo-Feng Zhang,et al.  Nicotine Induces Hypoxia-Inducible Factor-1α Expression in Human Lung Cancer Cells via Nicotinic Acetylcholine Receptor–Mediated Signaling Pathways , 2007, Clinical Cancer Research.

[13]  Li Wang,et al.  [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer]. , 2006, Ai zheng = Aizheng = Chinese journal of cancer.

[14]  W. Seeger,et al.  HIF-1alpha attenuates tumor growth in spite of augmented vascularization in an A549 adenocarcinoma mouse model. , 2005, International journal of oncology.

[15]  W. Aird,et al.  Vascular Endothelial Growth Factor Activates PI3K/Akt/Forkhead Signaling in Endothelial Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[17]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.